Found: 30
Select item for more details and to access through your institution.
pDCs efficiently process synthetic long peptides to induce functional virus- and tumour-specific T-cell responses.
- Published in:
- European Journal of Immunology, 2014, v. 44, n. 10, p. 2880, doi. 10.1002/eji.201444588
- By:
- Publication type:
- Article
A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 1897, doi. 10.3390/ijms24031897
- By:
- Publication type:
- Article
Unique CLR expression patterns on circulating and tumorinfiltrating DC subsets correlated with clinical outcome in melanoma patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1040600
- By:
- Publication type:
- Article
Melanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells.
- Published in:
- Scientific Reports, 2016, p. 30405, doi. 10.1038/srep30405
- By:
- Publication type:
- Article
Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00112
- By:
- Publication type:
- Article
A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells.
- Published in:
- PLoS ONE, 2010, v. 5, n. 5, p. 1, doi. 10.1371/journal.pone.0010458
- By:
- Publication type:
- Article
Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00861
- By:
- Publication type:
- Article
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2206, doi. 10.3390/cancers15082206
- By:
- Publication type:
- Article
Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3820, doi. 10.3390/cancers12123820
- By:
- Publication type:
- Article
Reply to Comment on "Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges" Cancers 2019, 11, 1554.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2673, doi. 10.3390/cancers12092673
- By:
- Publication type:
- Article
Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1554, doi. 10.3390/cancers11101554
- By:
- Publication type:
- Article
A Safe Bacterial Microsyringe for In Vivo Antigen Delivery and Immunotherapy.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 5, p. 1076, doi. 10.1038/mt.2013.41
- By:
- Publication type:
- Article
Dendritic cell subsets in health and disease.
- Published in:
- Immunological Reviews, 2007, v. 219, n. 1, p. 118, doi. 10.1111/j.1600-065X.2007.00551.x
- By:
- Publication type:
- Article
Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1148111
- By:
- Publication type:
- Article
Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation.
- Published in:
- Transplant International, 2024, p. 1, doi. 10.3389/ti.2024.12330
- By:
- Publication type:
- Article
Imiquimod Inhibits Melanoma Development by Promoting pDC Cytotoxic Functions and Impeding Tumor Vascularization.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 10, p. 2551, doi. 10.1038/jid.2014.194
- By:
- Publication type:
- Article
HLA-A<sup>*</sup>0201<sup>+</sup> Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients.
- Published in:
- Journal of Investigative Dermatology, 2012, v. 132, n. 10, p. 2395, doi. 10.1038/jid.2012.152
- By:
- Publication type:
- Article
Characterization of Circulating Dendritic Cells in Melanoma: Role of CCR6 in Plasmacytoid Dendritic Cell Recruitment to the Tumor.
- Published in:
- Journal of Investigative Dermatology, 2010, v. 130, n. 6, p. 1646, doi. 10.1038/jid.2010.24
- By:
- Publication type:
- Article
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0158297
- By:
- Publication type:
- Article
Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0156200
- By:
- Publication type:
- Article
Adenovirus-Inspired Virus-Like-Particles Displaying Melanoma Tumor Antigen Specifically Target Human DC Subsets and Trigger Antigen-Specific Immune Responses.
- Published in:
- Biomedicines, 2022, v. 10, n. 11, p. 2881, doi. 10.3390/biomedicines10112881
- By:
- Publication type:
- Article
Diversification of circulating and tumor‐infiltrating plasmacytoid DCs towards the P3 (CD80<sup>+</sup> PDL1<sup>−</sup>)‐pDC subset negatively correlated with clinical outcomes in melanoma patients.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 5, p. 1, doi. 10.1002/cti2.1382
- By:
- Publication type:
- Article
Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 11, p. 1, doi. 10.1002/cti2.1329
- By:
- Publication type:
- Article
Hepatitis B virus exploits C‐type lectin receptors to hijack cDC1s, cDC2s and pDCs.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 12, p. 1, doi. 10.1002/cti2.1208
- By:
- Publication type:
- Article
BDCA1<sup>+</sup> cDC2s, BDCA2<sup>+</sup> pDCs and BDCA3<sup>+</sup> cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 11, p. 1, doi. 10.1002/cti2.1190
- By:
- Publication type:
- Article
Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy.
- Published in:
- Immunology, 2024, v. 173, n. 1, p. 33, doi. 10.1111/imm.13801
- By:
- Publication type:
- Article
Melanoma tumour‐derived glycans hijack dendritic cell subsets through C‐type lectin receptor binding.
- Published in:
- Immunology, 2024, v. 171, n. 2, p. 286, doi. 10.1111/imm.13717
- By:
- Publication type:
- Article
T‐cell receptor diversity as a prognostic biomarker in melanoma patients.
- Published in:
- Pigment Cell & Melanoma Research, 2020, v. 33, n. 4, p. 612, doi. 10.1111/pcmr.12866
- By:
- Publication type:
- Article
The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients.
- Published in:
- Pigment Cell & Melanoma Research, 2018, v. 31, n. 1, p. 82, doi. 10.1111/pcmr.12618
- By:
- Publication type:
- Article
Exploration of the Lysis Mechanisms of Leukaemic Blasts by Chimaeric T-Cells.
- Published in:
- Journal of Biomedicine & Biotechnology, 2010, p. 1, doi. 10.1155/2010/234540
- By:
- Publication type:
- Article